| Nov 6 |
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET
|
| Oct 25 |
Fulcrum Before Q3 Earnings: How Should Investors Play the Stock?
|
| Oct 21 |
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow
|
| Oct 18 |
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
|
| Oct 9 |
Fulcrum Therapeutics Inc (FULC) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...
|
| Oct 9 |
Fulcrum Stock Tanks 58% in a Month: Buying Opportunity or Risky Bet?
|
| Oct 7 |
FMR LLC's Strategic Reduction in Fulcrum Therapeutics Inc Shares
|
| Oct 4 |
Down -57.53% in 4 Weeks, Here's Why Fulcrum Therapeutics (FULC) Looks Ripe for a Turnaround
|
| Sep 26 |
Fulcrum Therapeutics swings up 17% on Pfizer sickle cell drug setback
|
| Sep 24 |
Fulcrum reduces its workforce
|
